Data as of Sep 19
| +0.70 / +0.68%|
The 17 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 100.00, with a high estimate of 120.00 and a low estimate of 73.00. The median estimate represents a -3.86% decrease from the last price of 104.02.
The current consensus among 21 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.